cAMP signalling in insulin and glucagon secretion
- PMID: 28466587
- DOI: 10.1111/dom.12993
cAMP signalling in insulin and glucagon secretion
Abstract
The "second messenger" archetype cAMP is one of the most important cellular signalling molecules with central functions including the regulation of insulin and glucagon secretion from the pancreatic β- and α-cells, respectively. cAMP is generally considered as an amplifier of insulin secretion triggered by Ca2+ elevation in the β-cells. Both messengers are also positive modulators of glucagon release from α-cells, but in this case cAMP may be the important regulator and Ca2+ have a more permissive role. The actions of cAMP are mediated by protein kinase A (PKA) and the guanine nucleotide exchange factor Epac. The present review focuses on how cAMP is regulated by nutrients, hormones and neural factors in β- and α-cells via adenylyl cyclase-catalysed generation and phosphodiesterase-mediated degradation. We will also discuss how PKA and Epac affect ion fluxes and the secretory machinery to transduce the stimulatory effects on insulin and glucagon secretion. Finally, we will briefly describe disturbances of the cAMP system associated with diabetes and how cAMP signalling can be targeted to normalize hypo- and hypersecretion of insulin and glucagon, respectively, in diabetic patients.
Keywords: glucagon; incretins; insulin secretion; islets; type 2 diabetes; β-cell.
© 2017 John Wiley & Sons Ltd.
Similar articles
-
Cooperation between cAMP signalling and sulfonylurea in insulin secretion.Diabetes Obes Metab. 2014 Sep;16 Suppl 1:118-25. doi: 10.1111/dom.12343. Diabetes Obes Metab. 2014. PMID: 25200305 Review.
-
Cyclic AMP dynamics in the pancreatic β-cell.Ups J Med Sci. 2012 Nov;117(4):355-69. doi: 10.3109/03009734.2012.724732. Epub 2012 Sep 13. Ups J Med Sci. 2012. PMID: 22970724 Free PMC article. Review.
-
CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.Diabetologia. 2016 Sep;59(9):1928-37. doi: 10.1007/s00125-016-4020-6. Epub 2016 Jun 23. Diabetologia. 2016. PMID: 27338624
-
Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells.Diabetologia. 2011 Feb;54(2):390-402. doi: 10.1007/s00125-010-1955-x. Epub 2010 Nov 3. Diabetologia. 2011. PMID: 21046358
-
Somatostatin and insulin mediate glucose-inhibited glucagon secretion in the pancreatic α-cell by lowering cAMP.Am J Physiol Endocrinol Metab. 2015 Jan 15;308(2):E130-43. doi: 10.1152/ajpendo.00344.2014. Epub 2014 Nov 18. Am J Physiol Endocrinol Metab. 2015. PMID: 25406263 Free PMC article.
Cited by
-
Gsα-dependent signaling is required for postnatal establishment of a functional β-cell mass.Mol Metab. 2021 Nov;53:101264. doi: 10.1016/j.molmet.2021.101264. Epub 2021 Jun 4. Mol Metab. 2021. PMID: 34091063 Free PMC article.
-
Monoclonal therapy against calcitonin gene-related peptide lowers hyperglycemia and adiposity in type 2 diabetes mouse models.Metabol Open. 2020 Oct 8;8:100060. doi: 10.1016/j.metop.2020.100060. eCollection 2020 Dec. Metabol Open. 2020. PMID: 33089134 Free PMC article.
-
Differential immune gene expression associated with contemporary range expansion in two invasive rodents in Senegal.Sci Rep. 2020 Oct 26;10(1):18257. doi: 10.1038/s41598-020-75060-2. Sci Rep. 2020. PMID: 33106535 Free PMC article.
-
Modeling the Amino Acid Effect on Glucagon Secretion from Pancreatic Alpha Cells.Metabolites. 2022 Apr 13;12(4):348. doi: 10.3390/metabo12040348. Metabolites. 2022. PMID: 35448534 Free PMC article.
-
Insulin Release Mechanism Modulated by Toxins Isolated from Animal Venoms: From Basic Research to Drug Development Prospects.Molecules. 2019 May 14;24(10):1846. doi: 10.3390/molecules24101846. Molecules. 2019. PMID: 31091684 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous